Skip to main content
OpenTrials

Clinical trial condition

Corticosteroid Refractory Acute Graft vs Host Disease

Explore clinical trials studying Corticosteroid Refractory Acute Graft vs Host Disease. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Corticosteroid Refractory Acute Graft vs Host Disease trial results

Completed

Safety and Efficacy of Ruxolitinib Versus Best Available Therapy in Patients With Corticosteroid-refractory Acute Graft vs. Host Disease After Allogeneic Stem Cell Transplantation

NCT02913261

Conditions
Corticosteroid Refractory Acute Graft vs Host Disease, Graft vs Host Disease, Immune System Diseases
Locations
  • Novartis Investigative Site Westmead, New South Wales, Australia
  • Novartis Investigative Site Herston, Queensland, Australia
  • Novartis Investigative Site Parkville, Victoria, Australia
  • Novartis Investigative Site Murdoch, Western Australia, Australia
View all 103 locations
View Trial Details

Related conditions